{"id":1857,"date":"2001-10-01T12:06:00","date_gmt":"2001-10-01T10:06:00","guid":{"rendered":"https:\/\/der-arzneimittelbrief.com\/artikel\/2001\/frischzellen-fuer-das-herz"},"modified":"2001-10-01T12:06:00","modified_gmt":"2001-10-01T10:06:00","slug":"frischzellen-fuer-das-herz","status":"publish","type":"post","link":"https:\/\/der-arzneimittelbrief.com\/artikel\/2001\/frischzellen-fuer-das-herz","title":{"rendered":"Frischzellen f\u00fcr das Herz?"},"content":{"rendered":"<p>Welch \u00fcppige Bl\u00fcten die derzeitige Diskussion um die Therapie mit humanen adulten Stammzellen treibt, zeigt eine Publikation aus der kardiologischen Universit\u00e4tsklinik in D\u00fcsseldorf (Strauer, B.E., et al.: Dtsch. med. Wschr. 2001, 126, 932). Dort wurden einem 46-j\u00e4hrigem Mann f\u00fcnf Tage nach Vorderwand-Herzinfarkt (CK maximal 1172 U\/L) mononukle\u00e4re Zellen aus dem eigenen Knochenmark (enthalten u.a. kleine [&hellip;]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Welch \u00fcppige Bl\u00fcten die derzeitige Diskussion um die Therapie mit humanen adulten Stammzellen treibt, zeigt eine Publikation aus der kardiologischen Universit\u00e4tsklinik in D\u00fcsseldorf (Strauer, B.E., et al.: Dtsch. med. Wschr. 2001, 126, 932). Dort wurden einem 46-j\u00e4hrigem Mann f\u00fcnf Tage nach Vorderwand-Herzinfarkt (CK maximal 1172 U\/L) mononukle\u00e4re Zellen aus dem eigenen Knochenmark (enthalten u.a. kleine [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[71,3110,3109,65,2773],"class_list":["post-1857","post","type-post","status-publish","format-standard","hentry","category-allgemein","tag-herzinfarkt","tag-knochenmarkzellen","tag-mononukleaere-zellen","tag-myokardinfarkt","tag-stammzellen"],"_links":{"self":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/1857","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/comments?post=1857"}],"version-history":[{"count":0,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/1857\/revisions"}],"wp:attachment":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/media?parent=1857"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/categories?post=1857"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/tags?post=1857"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}